CME Financial Statements From 2010 to 2024
| MX4A Stock | EUR 227.00 3.75 1.68% |
Check CME financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CME's main balance sheet or income statement drivers, such as , as well as many indicators such as . CME financial statements analysis is a perfect complement when working with CME Valuation or Volatility modules.
CME |
CME Group Company Return On Asset Analysis
CME's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current CME Return On Asset | 0.0101 |
Most of CME's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CME Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, CME Group has a Return On Asset of 0.0101. This is 102.15% lower than that of the Financial Services sector and 99.53% lower than that of the Financial Exchanges industry. The return on asset for all Germany stocks is 107.21% lower than that of the firm.
CME Group Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CME's current stock value. Our valuation model uses many indicators to compare CME value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CME competition to find correlations between indicators driving CME's intrinsic value. More Info.CME Group is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.10 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CME Group is roughly 9.82 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CME's earnings, one of the primary drivers of an investment's value.About CME Financial Statements
CME stakeholders use historical fundamental indicators, such as CME's revenue or net income, to determine how well the company is positioned to perform in the future. Although CME investors may analyze each financial statement separately, they are all interrelated. For example, changes in CME's assets and liabilities are reflected in the revenues and expenses on CME's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CME Group. Please read more on our technical analysis and fundamental analysis pages.
CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois. CME GROUP operates under Financial Exchanges classification in Germany and is traded on Frankfurt Stock Exchange. It employs 4590 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in CME Stock
When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:Check out the analysis of CME Correlation against competitors. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.